India to Set Up Digital Portal to Track Narcotic Drugs Soon

India is moving ahead with a digital portal to track narcotic drugs, a step aimed at tightening oversight on controlled medicines.

The proposed digital portal to track narcotic drugs will create a centralized system to monitor the movement and use of sensitive substances across the country, addressing long-standing gaps in regulation.

The decision comes after discussions within the Drug Consultative Committee, which recommended building a unified digital framework.

Also Read: How Digital Maturity is Powering Pharma's GMP Evolution

Officials believe the platform will help authorities keep a close watch on how narcotic and psychotropic drugs move through the supply chain, from manufacturers to pharmacies.

The new system is expected to capture real-time data, making it easier to detect irregular patterns, prevent illegal diversion, and curb misuse of prescription medicines. This aligns with broader efforts to strengthen the India drug monitoring system and improve accountability across the pharmaceutical sector.

The digital portal to track narcotic drugs will also support coordination between regulators and enforcement agencies. By having access to a single database, officials can act faster when discrepancies arise, reducing the risk of these drugs being misused or entering unauthorized markets.

This move signals a clear shift toward tech-driven regulation in India’s pharma space. As concerns grow around the misuse of controlled substances, the government is focusing on stronger tracking mechanisms to ensure these medicines are used strictly for medical purposes.